Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 16,312 shares at $45.12 ($737K) on 2016-03-15, disclosed to the SEC on 2016-03-17.
Open-market sale of $737k KITE by VP Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.12 | 7,812 | $352K | 47.8% |
| 2 | $45.12 | 7,812 | $352K | 47.8% |
| 3 | $46.55 | 499 | $23K | 3.2% |
| 4 | $48.07 | 189 | $9K | 1.2% |
| Total | $45.20 avg | 16,312 | $737K | 100% |
| Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |
| KITE | SELL | 2015-11-18 | $748K | — | Filing → |
| KITE | SELL | 2015-10-19 | $599K | — | Filing → |